サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1611217

ヒト胚性幹細胞の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年

Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒト胚性幹細胞の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年11月22日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒト胚性幹細胞市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のヒト胚性幹細胞市場規模は2030年までに40億米ドルに達し、2025～2030年のCAGRは10.44％で成長すると予測されています。

hESCs技術は、宿主と移植片の組織適合性が高いため、ヒトの組織工学に有用な傾向があります。

3つの生殖細胞層すべての誘導体への寄与という発生能の維持は、これらの細胞の重要な特徴です。この能力は、クローン誘導や長期の未分化な増殖の後でも一貫して維持されており、そのため取り込みが促進されます。

さらに、これらの細胞は高レベルのアルカリホスファターゼ、主要転写因子、テロメラーゼを発現する能力があります。これらの因子は、細胞内部の多能性の維持に非常に重要であることが分かっています。

さらに、hESCは神経細胞、神経系、オリゴデンドロサイト、アストロサイトに容易に分化させることができます。前述の特徴は、神経発生初期に起こる一連の出来事を研究するのに有用です。

しかし、生存可能な胚に由来する幹細胞を使用することは倫理的な問題をはらんでいるため、科学者たちはESCを作製する他の方法を模索しています。他の方法には、胚性生殖細胞の誘導、死んだ胚からの幹細胞、その他の技術が含まれます。

ヒト胚性幹細胞市場レポートハイライト

  • 再生医療が2024年に54.18%のシェアで市場を独占。再生医療は、いくつかの疾患の治療に大きな進歩をもたらします。さらに、ヒト胚に由来する多能性細胞は、生物医療研究の中心となっています。
  • 幹細胞生物学研究セグメントは、予測期間中に最も高いCAGRを示すと考えられます。いくつかのバイオ製薬企業は、過去に幹細胞生物学の可能性を探ってきました。
  • 北米のヒト胚性幹細胞は、強固な研究インフラ機関や施設を背景に、2024年の市場を独占しました。慢性疾患や遺伝性疾患の増加により、遺伝子治療に対する大きな需要が生まれている
  • アジア太平洋のヒト胚性幹細胞市場は、予測期間中に大きな成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 産業分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 ヒト胚性幹細胞市場：用途ビジネス分析

  • セグメントダッシュボード
  • 世界のヒト胚性幹細胞市場の用途変動分析
  • 世界のヒト胚性幹細胞市場規模と動向分析、用途別、2018～2030年
  • 再生医療
  • 幹細胞生物学研究
  • 組織工学
  • 毒性検査

第5章 ヒト胚性幹細胞市場：地域別、推定・動向分析

  • 地域ダッシュボード
  • 市場規模と予測と動向分析、2018～2030年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカのヒト胚性幹細胞市場、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカのヒト胚性幹細胞市場、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参入企業
  • 戦略マッピング
  • 企業市況分析、2024年
  • 参入企業概要
    • Thermo Fisher Scientific, Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Sartorius AG
    • PromoCell GmBH
    • Takara Bio
    • Lonza
    • Cellartis AB
    • ATCC
    • AcceGen
    • Cell Applications, Inc.
    • Bio-techne
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Human Embryonic Stem Cells Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 14 France Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 17 Denmark Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Sweden Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 19 Norway Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Japan Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 23 China Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 24 India Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 25 South Korea Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 26 Australia Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 27 Thailand Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 28 LATAM Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 29 LATAM Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Brazil Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 32 MEA Human Embryonic Stem Cells Market, by country, 2018 - 2030 (USD Million)
  • Table 33 MEA Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Human Embryonic Stem Cells Market, by application, 2018 - 2030 (USD Million)
  • Table 38 Participant's overview
  • Table 39 Financial performance
  • Table 40 Key companies undergoing expansions
  • Table 41 Key Companies Undergoing Acquisitions
  • Table 42 Key Companies Undergoing Collaborations
  • Table 43 Key companies launching new products
  • Table 44 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Human Embryonic Stem Cells Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Human Embryonic Stem Cells Market Driver Analysis
  • Fig. 12 Human Embryonic Stem Cells Market Restraint Analysis
  • Fig. 13 Human Embryonic Stem Cells Market: Porter's analysis
  • Fig. 14 Human Embryonic Stem Cells Market: PESTEL analysis
  • Fig. 15 Human Embryonic Stem Cells Market: Application outlook and key takeaways
  • Fig. 16 Human Embryonic Stem Cells Market: Application market share analysis, 2023 - 2030
  • Fig. 17 Global regenerative medicine market, 2018 - 2030 (USD Million)
  • Fig. 18 Global stem cell biology research market, 2018 - 2030 (USD Million)
  • Fig. 19 Global tissue engineering market, 2018 - 2030 (USD Million)
  • Fig. 20 Global toxicology testing market, 2018 - 2030 (USD Million)
  • Fig. 21 Regional marketplace: Key takeaways
  • Fig. 22 North America Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Canada Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • Fig. 26 Europe Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 UK Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Germany Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Spain Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Italy Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 France Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Denmark Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Sweden Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Norway Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Asia-Pacific Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Japan Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 China Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 India Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Australia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Thailand Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 LATAM Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Brazil Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Argentina Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 MEA Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Saudi Arabia Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 South Africa Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 UAE Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Kuwait Human Embryonic Stem Cells Market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Key company categorization
  • Fig. 52 Company market positioning
  • Fig. 53 Market Participant categorization
  • Fig. 54 Strategy framework
目次
Product Code: GVR-1-68038-394-2

Human Embryonic Stem Cells Market Growth & Trends:

The global human embryonic stem cells market size is expected to reach USD 4.00 billion by 2030, registering to grow at a CAGR of 10.44% from 2025 to 2030 according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.

Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.

In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.

Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.

However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.

Human Embryonic Stem Cells Market Report Highlights:

  • Regenerative medicines dominated the market with a share of 54.18% in 2024. Regenerative medicines offer significant advancements in treating several diseases. Moreover, pluripotent cells originating from human embryos have been central to biomedical research.
  • The stem cell biology research segment will witness the highest CAGR over the forecast period. Several biopharmaceutical companies have explored the potency of stem cell biology in the past.
  • North America human embryonic stem cells dominated the market in 2024 owing to robust research infrastructure institutions and facilities. The rise in chronic diseases and genetic disorders has created a huge demand for gene therapies.
  • Asia Pacific human embryonic stem cell market is anticipated to witness significant growth in the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Application
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Human Embryonic Stem Cells Market: Application Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Human Embryonic Stem Cells Market Application Movement Analysis
  • 4.3. Global Human Embryonic Stem Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 4.4. Regenerative Medicine
    • 4.4.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Stem Cell Biology Research
    • 4.5.1. Global Stem Cell Biology Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Tissue Engineering
    • 4.6.1. Global Tissue Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Toxicology Testing
    • 4.7.1. Global Toxicology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis by Application

  • 5.1. Regional Dashboard
  • 5.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 5.3. North America
    • 5.3.1. North America Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Scenario
      • 5.3.4.4. Mexico Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Denmark
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Denmark Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Sweden Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Norway Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Japan Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. China Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. South Korea Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Australia
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Australia Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Thailand
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Thailand Human Embryonic Stem Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Scenario
      • 5.6.2.4. Brazil Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Scenario
      • 5.6.3.4. Argentina Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Scenario
      • 5.7.2.4. South Africa Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Scenario
      • 5.7.3.4. Saudi Arabia Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Scenario
      • 5.7.4.4. UAE Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Scenario
      • 5.7.5.4. Kuwait Human Embryonic Stem Cells Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Position Analysis, 2024
  • 6.4. Participant's Overview
    • 6.4.1. Thermo Fisher Scientific, Inc.
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. STEMCELL Technologies
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Merck KGaA
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Sartorius AG
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. PromoCell GmBH
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Takara Bio
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Lonza
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Cellartis AB
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. ATCC
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. AcceGen
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Cell Applications, Inc.
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. Bio-techne
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives